5.93

5.27% -0.33

After Hours: 5.93

Fortrea Holdings Inc (FTRE)

Overview News Price History Option Chain Financials Why FTRE Down? Discussions Forecast

Fortrea Holdings Inc stock is traded at $5.93, with a volume of 1.89M. It is down -5.27% in the last 24 hours and down -8.20% over the past month. Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Previous Close:

$6.26

Open:

$6.24

24h Volume:

1.89M

Relative Volume:

0.84

Market Cap:

$550.49M

Revenue:

$2.98B

Net Income/Loss:

$-300.00M

P/E Ratio:

-1.7441

EPS:

-3.4

Net Cash Flow:

$225.00M

1W Performance:

-2.47%

1M Performance:

-8.20%

6M Performance:

-65.32%

1Y Performance:

-84.15%

1-Day Range:

$5.91

$6.28

1-Week Range:

$5.91

$6.38

52-Week Range:

$4.77

$37.24

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name

Fortrea Holdings Inc

Sector

Healthcare (1150)

Industry

Biotechnology (676)

Phone

877-495-0816

Address

8 MOORE DRIVE, DURHAM

Employee

15,500

Twitter

Next Earnings Date

2025-03-03

Latest SEC Filings

FTRE's Discussions on Twitter

Compare FTRE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FTRE Fortrea Holdings Inc	5.93	550.49M	2.98B	-300.00M	225.00M	-3.40
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Downgrade	Barclays	Equal Weight → Underweight
Dec-11-24	Downgrade	Citigroup	Buy → Neutral
Dec-06-24	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-08-24	Downgrade	Evercore ISI	Outperform → In-line
Jul-24-24	Resumed	Barclays	Equal Weight
Jun-06-24	Initiated	Goldman	Neutral
May-29-24	Initiated	TD Cowen	Hold
May-28-24	Initiated	Mizuho	Neutral
Mar-22-24	Initiated	Robert W. Baird	Neutral
Mar-06-24	Initiated	Deutsche Bank	Hold
Jan-05-24	Initiated	William Blair	Mkt Perform
Jan-04-24	Initiated	Jefferies	Buy
Dec-11-23	Upgrade	Citigroup	Neutral → Buy
Dec-01-23	Upgrade	Evercore ISI	In-line → Outperform
Nov-14-23	Upgrade	Barclays	Equal Weight → Overweight
Oct-19-23	Initiated	Citigroup	Neutral
Sep-14-23	Initiated	Evercore ISI	In-line
Aug-16-23	Initiated	Barclays	Equal Weight
Aug-07-23	Initiated	BofA Securities	Underperform

View All

Fortrea Holdings Inc Stock (FTRE) Latest News

09:46 AM

Fortrea: 83% Price Drop But Not Yet An Investment Opportunity (NASDAQ:FTRE) - Seeking Alpha

09:46 AM

05:09 AM

Raymond James Financial Inc. Makes New $1.08 Million Investment in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

05:09 AM

02:41 AM

Fortrea (NASDAQ:FTRE) Research Coverage Started at Truist Financial - Defense World

02:41 AM

May 03, 2025

Wells Fargo & Company MN Sells 13,680 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

May 03, 2025

May 02, 2025

Fortrea (FTRE) Receives Hold Rating from Truist | FTRE Stock New - GuruFocus

May 02, 2025

Truist Initiates Fortrea Holdings at Hold With $7 Price Target - marketscreener.com

May 02, 2025

May 01, 2025

Cautious Hold Rating for Fortrea Holdings Amidst Execution Challenges and Industry Uncertainty - TipRanks

May 01, 2025

Fortrea (FTRE) Receives Hold Rating from Truist | FTRE Stock News - GuruFocus

May 01, 2025

Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025 - Yahoo Finance

May 01, 2025

Apr 28, 2025

Fortrea Holdings Inc Still Hasn’t Convinced Analysts? - Stocksregister

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Analysts Set Fortrea Holdings Inc. (NASDAQ:FTRE) Target Price at $16.70 - Defense World

Apr 27, 2025

Apr 26, 2025

Envestnet Asset Management Inc. Sells 66,515 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 26, 2025

Apr 25, 2025

Lost Money on Fortrea Holdings Inc.(FTRE)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire

Apr 25, 2025

Apr 24, 2025

Fortrea Holdings Inc Inc. (FTRE) Price Performance: The Role of Supply and Demand - investchronicle.com

Apr 24, 2025

Apr 23, 2025

Bank of Montreal Can Purchases 7,677 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 23, 2025

Invesco Ltd. Grows Stock Position in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 23, 2025

Apr 20, 2025

JPMorgan Chase & Co. Sells 129,863 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 20, 2025

Apr 18, 2025

Geode Capital Management LLC Sells 8,045 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 18, 2025

Apr 17, 2025

Alliancebernstein L.P. Buys 57,879 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 17, 2025

Apr 15, 2025

Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call - Bluefield Daily Telegraph

Apr 15, 2025

Apr 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc.FTRE - PR Newswire

Apr 14, 2025

Fortrea Holdings Inc. Faces Revenue and EBITDA Decline Amid Challenging Market Dynamics, Hold Rating Issued - TipRanks

Apr 14, 2025

BofA Securities Adjusts Price Target on Fortrea to $6 From $10 - marketscreener.com

Apr 14, 2025

Apr 13, 2025

Norges Bank Acquires Shares of 17,685 Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Apr 13, 2025

Apr 12, 2025

Barclays Downgrades Fortrea to Underweight From Equalweight, Cuts Price Target to $6 From $12 - MarketScreener

Apr 10, 2025

Apr 09, 2025

Demystifying Fortrea Holdings: Insights From 4 Analyst Reviews - Benzinga

Apr 09, 2025

Apr 08, 2025

Is Fortrea Holdings (NASDAQ:FTRE) Using Debt Sensibly? - simplywall.st

Apr 08, 2025

Fortrea Holdings Inc. (NASDAQ:FTRE) Shares Acquired by Sei Investments Co. - Defense World

Apr 08, 2025

Fortrea's SWOT analysis: life science tools firm faces headwinds, seeks growth - Investing.com

Apr 08, 2025

Apr 07, 2025